Cognitive impairment profile in patients with the m.3243A>G variant in mitochondrial DNA

Satu Winqvist1, Mikko Kärppä1,2,3, Jukka S Moilanen2,3,4

  • 1Neurocenter, Oulu University Hospital, Oulu, Finland.

BMC Neurology
|August 1, 2025
PubMed
Abstract

Insights

Cognitive impairment is common in patients with the m.3243A>G mitochondrial DNA variant, affecting 36% of individuals studied. Major cognitive impairment occurred in 13%, with executive functions most impacted.

Area of Science:

  • Neuroscience
  • Genetics
  • Mitochondrial Biology

Background:

  • The m.3243A>G variant in mitochondrial DNA presents a wide range of clinical symptoms.
  • Cognitive impairment is a known feature, but its prevalence and severity require further investigation.

Purpose of the Study:

  • To describe the neuropsychological features associated with the m.3243A>G mitochondrial DNA variant.
  • To determine the frequency and profile of cognitive impairment in affected individuals.

Main Methods:

  • A comprehensive neuropsychological test battery was administered to 45 adult patients with the m.3243A>G variant and 45 healthy controls.
  • Cognitive impairment was defined by impairment in at least five of seven cognitive domains compared to controls.

Main Results:

  • 36% of patients (16/45) were diagnosed with cognitive impairment, and 13% (6/45) had major cognitive impairment.
  • Impairment was observed across all neuropsychological domains, with executive functions most affected and verbal memory least affected.
  • Higher variant heteroplasmy and a more severe global phenotype correlated with cognitive impairment.

Conclusions:

  • Cognitive impairment is frequent in m.3243A>G variant carriers, though major impairment is less common.
  • The cognitive profile associated with this variant is broad, affecting all domains without a specific pattern.